The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples